
Baxdrostat offers hope for stubborn high blood pressure
A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high despite medication, according to the results of a Phase III clinical trial. The international BaxHTN trial, led by Professor Bryan Williams, UCL Institute of Cardiovascular Science, and sponsored by… Read More












